The existing literature on the magnetic resonance imaging of murine models of Alzheimer's disease is reviewed. Particular attention is paid to the possibilities for the early detection of the disease. To this effect, not only are relaxometric and volumetric approaches discussed, but also mathematical models for plaque distribution and aggregation. Image analysis plays a prominent role in this line of research, as stochastic image models and texture analysis have shown some success in the classification of subjects affected by Alzheimer's disease. It is concluded that relaxometric approaches seem to be a promising candidate for the task at hand, especially when combined with sophisticated image analysis, and when data from more than one time-point is available. There have been few longitudinal studies of mice models so far, so this direction of research warrants future efforts.
INTRODUCTION
Alzheimer s disease (AD) is an age-related neurodegenerative disease characterized by structural brain changes and were cognitive dysfunction. Due to the aging in western societies, AD will pose a large psychological and economical burden in the future [1] . Early detection of AD is therefore of considerable interest, since pharmacological treatment can reduce the amyloid burden and atrophy of the brain [2, 3] . The atrophy in the brain causes structural changes, which are detectable by various non-invasive imaging modalities [4, 5] and such considerations have led to the development of new imaging methodologies, for example diffusion-weighted magnetic resonance (MR) imaging [6, 7] , multiphoton microscopy [8] or positron emission tomography [9] .
The detection of AD by MR imaging techniques [10] is conveniently studied in standardized mouse models [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . Brain mapping techniques [18] can be used to quantify changes, for example in voxel-based morphometry [19, 20] , and more involved approaches estimate diffeomorphic changes in local brain structure [21] or construct local surface models [22] from volumetric measurements. Texture analysis is an interesting alternative [23] that has received little attention so far. The statistical analysis of MR images allows to discriminate between disease conditions [24, 25] . However, these analyses are often static, and do not usually incorporate knowledge about disease dynamics, molecular mechanisms [26, 27] or structural changes in time. The latter can in fact be inferred from longitudinal studies [28, 29] , whereby animal models are employed favorably [30] [31] [32] .
Many extensive review papers have been written on Alzheimer s disease in the past [11, [33] [34] [35] [36] [37] [38] ; it is not our intention to duplicate previous efforts. However, most reviews on AD concerned with small animal imaging focus on the development of mouse models or different scanning protocols to visualize plaques. In this paper we review the existing work on early detection of AD from serial MR images of transgenic mice, with special regard to the integration of dynamical information, i.e. how does (i) knowledge about AD dynamics from longitudinal studies, (ii) knowledge about developmental changes in brain structure and (iii) knowledge about disease processes at the molecular level help in the detection process? In particular, statistical and quantitative image analysis methods are addressed, and we subdivide them into volumetric approaches, relaxometric approaches, methods based on plaque burden evaluation, and methods based on texture analysis. Finally we give some recommendations for further research, by indicating gaps in the literature, interesting research directions and problems still to be solved.
ALZHEIMER MOUSE MODELS
Several of the genes involved in the development of familial AD have been isolated in human studies. These genes have been used to develop a wide variety of transgenic mouse models, all displaying one or more of the characteristic pathological features of the disease [33] . The most common lesions are schematically depicted in Fig. (1) : Senile plaques arising from amyloid-beta (A ) accumulation and inflammatory processes involving glial cells, neurofibrillary tangles (NFT) involving tau protein from the cytoskeleton of affected neurons, and vascular lesions caused by amyloidbeta deposits in cerebral arteries. A brief overview of several lines of transgenic mouse models is given in Tables  1 and 2 . Not all available mouse models are described, but those models which have either significantly advanced the understanding of AD pathogenesis or are otherwise in widespread use. This overview is adapted from the work of McGowan et al. [36] , and expanded upon with information obtained from the Alzheimer Research Forum 1 .
The work of Benveniste et al. [14] showed in 1999 that it is possible to visualize plaques in ex vivo samples of human brain by means of MR imaging. In vivo imaging of plaque deposition in human brains has so far not been successfully implemented. Visualization of plaques in mouse models at high field strengths has been successful, with first in vivo results reported in 2003 by Wadghiri et al. [62] . Since then, several groups have attempted to visualize plaque burden in vivo in different transgenic strains of mice, both with and without the aid of contrast agents. Furthermore, the development of plaques with age in individual mice has been successfully tracked using in vivo high resolution magnetic resonance imaging [30] . To date, the most commonly used AD models in this line of MRI research are doubly transgenic APP/PS1 strains [11, 15-17, 31, 62-68] , followed by singly transgenic APP strains [17, 30, 31, 62, 69, 70] . PS1 mouse models are occasionally used as controls, in addition to non-transgenic animals, as these animals have elevated A levels, but no A deposits.
RELAXOMETRY
In addition to anatomical or pathological features, several intrinsic MR parameters can be studied to determine the effect of disease progression. In relaxometric approaches, the 1 http://www.alzforum.org/res/com/tra/ T 1 (longitudinal, or spin-lattice) and T 2 (transverse, or spinspin) relaxation rates are commonly studied to facilitate the quantification of disease processes. T 1 specifies the rate at which the net magnetizations returns to its equilibrium state along the axis of the magnets bore, while T 2 specifies the rate at which the net magnetization in the transverse plane returns to zero after RF excitation. Alternate relaxation parameters are T 2 * and T 1rho . Unlike T 2 , the parameter T 2 * is influenced by magnetic field gradient inhomogeneities and its relaxation time is shorter than the T 2 relaxation time. The spin lattice relaxation time constant in the rotating frame, T 1rho , determines the decay of the transverse magnetization in the presence of a spin-lock radiofrequency (RF) field [15] .
Since both T 2 and T 1 relaxation times are sensitive to changes in biophysical water content it has been hypothesized that the presence of A deposits in the brain has an effect on these parameters [63] . As such they might be used as independent markers for changes occurring in tissue, averaged over a region of interest (ROI). In fact, even pathological changes below the MRI resolution, i.e., at the subvoxel level, could in principle be detected, as parameter values of a single voxel are the result of an averaging process (partial volume effect). Several groups have studied the effects of the progression of AD on the transverse relaxation rate T 2 ; there is a general consensus that the T 2 values of affected brain tissue are lower than in controls, and decrease further as AD progresses [30, 31, 63, 67] .
The analysis of relaxometric data in murine models of AD was first reported by Helpern et al. in 2004 [63] . In their work APP/PS1 mice were compared to PS1 mice and nontransgenic littermates. T 2 values were found to be significantly lower in the cortex, hippocampus and corpus callosum, when comparing doubly transgenic animals to PS1 and [39] : The first mutant amyloid precursor protein (APP) transgenic mouse model with robust plaque pathology. These mice express a human APP cDNA with the Indiana mutation (APPV717F). Plaque pathology starts between 6 9 months in hemizygous PDAPP mice. There is synapse loss, but cell loss and NFT pathology are not observed. This model has been used widely in vaccination therapy strategies.
Tg2576 [40] : This model expresses mutant APPSWE under control of the hamster prion promoter. Plaque pathology is observed from approximately 9 months of age onwards. These mice have cognitive deficits but show no cell loss or NFT pathology. Tg2576 is one of the most widely used transgenic models.
APP23 [41] [42] [43] : These mice express mutant APPSWE under control of the Thy1 promoter. Prominent cerebrovascular amyloid and cerebral amyloid deposits are observed from 6 months of age onwards. Some hippocampal neuronal loss in this model is associated with amyloid plaque formation.
TgCRND8 [44] : Mice express multiple APP mutations (Swedish plus Indiana). Cognitive deficits coincide here with rapid senile plaque development at approximately 3 months of age. The cognitive deficits can be reversed by A vaccination therapy.
PS1M146V and PS1M146L [45] : These models were the first in vivo demonstration that mutant presenilin 1 (PS1) selectively elevates A 42 levels. No overt plaque pathology is observed though.
PSAPP (Tg2576 PS1M146L [46] , PS1-A246E+APPSWE [47] ): A bigenic transgenic mouse model which showed that addition of the mutant PS1 transgene markedly accelerates amyloid pathology compared to singly transgenic mutant APP mice, demonstrating that the PS1-driven elevation of A 42 enhances plaque pathology.
APPDutch [48] : Mice expressing APP with the Dutch mutation, which causes hereditary cerebral hemorrhage with amyloidosis in humans, develop severe congophilic amyloid angiopathy. The addition of a mutant PS1 transgene redistributes the amyloid pathology to the parenchyma, indicating differing roles for A 40 and A 42 in vascular and parenchymal amyloid pathology. [49] : These mice express individual A isoforms without over-expression of APP [49] . Only mice expressing A 42 develop senile plaques and CAA, whereas BRI-A 40 mice do not develop plaques, suggesting that A 42 is essential for plaque formation.
BRI-A 40 and BRI-A 42
JNPL3 [50] : These mice express 4R0N microtubule associated protein tau (MAPT) with the P301L mutation.This is the first transgenic mouse model with a marked tangle pathology and cell loss, demonstrating that tau protein alone can cause cellular damage and neuronal loss. JNPL3 mice develop motor impairments with age owing to severe pathology and motor neuron loss in the spinal cord.
TauP301S [51] : This line of mice expresses the shortest isoform of 4R MAPT with the P301S mutation. Homozygous mice develop severe paraparesis at 5-6 months of age with widespread neurofibrillary pathology in the brain and spinal cord, and neuronal loss in the spinal cord.
TauV337M [52] : Mice express low level synthesis of 4R MAPT with the V337M mutation (1/10 of endogenous mouse MAPT) driven by the promoter of platelet-derived growth factor (PDGF). The development of neurofibrillary pathology in these mice suggests the nature of tau rather than absolute intracellular tau concentrations drives pathology.
TauR406W [53] : Mice express 4R human MAPT with the R406W mutation under control of the CAMKII promoter. These mice develop MAPT inclusions in the forebrain from 18 months of age onward and have impaired associative memory.
rTg4510 mice have inducible MAPT using the TET-off system [54] [55] . Abnormal MAPT pathology occurs from one month of age on. These mice show progressive NFT pathology and severe cell loss. Cognitive deficits are evident from 2.5 months of age onwards.
Htau [56] : These transgenic mice express human genomic MAPT only (mouse MAPT knocked-out). Htau mice accumulate hyperphosphorylated tau from 6 months on and develop Thio-S-positive NFT by the time they are 15 months old.
TAPP (Tg2576 JNPL3) mice have increased MAPT forebrain pathology when compared to JNPL3 mice, suggesting mutant APP and/or A can affect downstream MAPT pathology [57] .
3 TgAD [58, 59] : This is a triple transgenic model expressing mutant APPSWE and MAPTP301L on a PS1M146V knock-in background (PS1-KI). This line develops plaques from 6 months on, and MAPT pathology from the time they are 12 months old, strengthening the hypothesis that neurofibrillary pathology can be directly influenced by APP or A APP717I mice express human APP cDNA with the London mutation (APPV717I) [60] . This strain displays decreased exploration, increased neophobicity and increased male aggressiveness. Pathological features include amyloid plaques and cerebrovascular angiopathy with an onset around 10-12 months, and cholinergic fiber distortion.
APPV717I ADAM10-dn [61] : Double transgenic mice expressing both APPV717I and a proteinase of the ADAM (a disintegrin and metalloproteinase) family. Expression of ADAM10-dn leads to an enhancement of the number and size of amyloid plaques in the brains of these double-transgenic mice. However, compared to APPV717I mice, they exhibit improved performance in the Morris water maze test. [31] . This study revealed that only the APP and APP/PS1 groups show significant changes in T 2 compared to non-transgenic controls. Table 3 presents an overview of relaxometric research in AD mouse models. The statistical analysis of relaxometric data in its simplest form is based on summary statistics over a region of interest (ROI), which is usually much larger than the resolu- Tg, transgenic; Ntg, non-transgenic. *Several mice at each time point were measured longitudinally. However, as the experiment progressed, several of the mice that the experiment was started with were no longer included. To maintain the original number of animals, those that dropped out were replaced with new ones.
tion achieved, encompassing a number of voxels on the order of ten or more. To compare the values of these variables between subjects and over the course of time (in one or more subjects), the images need to be registered with respect to each other. Between groups of subjects affected by AD and control subjects, there exist significant differences between relaxometric rates. P-values can be derived from the empirical standard deviation by assuming normality of the underlying population and relating this to Student's t-distribution. forating arteries of APP23 mice corresponded to the occurrence of blood flow disturbances. Similarly, CAA-related capillary occlusion was observed in the occipital cortex of human AD subjects more frequently than in controls.
VOLUMETRIC METHODS
Brain atrophy has been pointed out as a biomarker for the development of Alzheimer s disease in human patients with Mild Cognitive Impairment (MCI) [109] [110] [111] [112] [113] . Most studies reported neurodegeneration in the structures of the mesial temporal lobe, such as the hippocampus, parahippocampal gyrus and amygdala, as a result of Alzheimer's disease. Brain atrophy can be quantified and followed in time by performing volumetric measurements in MRI. Voxel-based morphometry is an essential step in these types of analysis [114] , and it is crucial that the necessary image registration steps are performed correctly [115] . A review paper on this topic was recently published by Ramani et al. [6] . Although there is overwhelming evidence on the utility of volumetric biomarkers from human studies, most research in the development of transgenic mouse models has focused on models which develop A aggregation (diffuse plaques and amyloid plaques), usually combined with an emphasis on astro-and microgliosis. Only in the last decade, small animal research has turned towards the study of neurodegeneration of specific brain regions. Recently it has been found that the progression of amyloid deposition in APP mouse strains is correlated to a decrease in neurogenesis in the hippocampal region [116] .
Brain morphometry in transgenic mouse models of Alzheimer s disease is challenging due to the small size of the structures of interest in the brain and the low contrast between these structures. Although manual segmentation is still considered as the gold standard in morphometric studies, the variability in these findings is large [117] . This problem is overcome by automated segmentation methods, which not only reduce the amount of time needed for delineation, but also improve the objectivity and repeatability of the segmentation, especially when a brain atlas is used as a template [13] . MRI enables the creation of digital atlases to describe the anatomy of mice [118, 119] by averaging normalized MRI scans of a group of animals. This has been of considerable interest in the analysis of various phenotypes [117, 120, 121] and is used in the comparative analysis of both in vivo [122] and ex vivo MR images [123, 124] . An example of such an atlas is shown in Fig. (2) . To study brain atrophy it is a prerequisite to compare images to an atlas and several studies employ registration algorithms to automatically perform this task. Nonlinear registration is generally superior to simple affine registration, although it is much more sensitive to noise and image distortion. MR images of high quality are therefore required for nonlinear registration [39] . Another way of to study neuroanatomical differences between mouse strains is the statistical analysis of landmark points after nonlinear registration, as employed by Chen et al. [25] . Falangola et al. [67] applied nonlinear registration techniques to quantify group averages of three distinct mouse strains and proved that nonlinear registration is able to detect small differences of in vivo MR images. In addition to cross-sectional studies, longitudinal studies can be performed. Verma et al. created a longitudinal map of the average brain development in multiple C57BL/6J mice [125] , the so-called spatio-temporal heterogeneity map of brain development and maturation. Recently, Maheswaran et al. applied non linear deformation analysis to both in vivo cross sectional as well as longitudinal studies [126] .
TEXTURE ANALYSIS
The texture of an image is an elusive concept that can be roughly defined as its statistical properties at different levels of scale [127] . Above we have already discussed the characterization of plaque burden in terms of stochastic image models, which is a particular approach. Here we discuss three more branches of texture analysis (also see [23, 73, 128, 129] ). The statistical approach is specifically targeted at discrimination purposes. To this respect, from a given image or a ROI a number of feature descriptors are computed. The classic example are gray-level co-occurrence matrices (GLCM) in 2D [130] . Let (i,j) be a displacement vector in 2D. For each possible pair (r,s) of gray-level values, i.e., discretized relaxation rates for our purposes, its number of occurrences in the image X is counted. All such co-occurrences define a symmetric matrix C(r,s | i,j) = |{(k,l) | X kl = r, X k±i,l±j = s }|. Two examples are shown in Fig. (3) , where for simplicity the MR parameter has been discretized at 8 levels. For each of these matrices, distinct statistical measures can be defined. The energy of the matrix is the sum of its squared entries C 2 (r,s | i,j), and quantifies the image inhomogeneity. The contrast is the sum of |r-s| 2 · C(r,s | i,j) over all pairs (r,s), and measures local image variations.
Other commonly used feature descriptors are entropy measures, which can also be directly estimated from images [131] . The latter has been applied to T 2 images in a cuprizone mouse model, for example [132] . With respect to Alzheimer's disease, Freeborough and co-workers used a total of 17 feature descriptors, selected from an initial set of 260 descriptors, most derived from GLCMs, to classify and track the progression of the disease in T 1 images of human brains [133] . Liu and colleagues used an initial set of 3456 descriptors to classify T 1 images of humans [134] . The crossvalidated accuracy exceeded 90 percent in both cases. Kovalev and colleagues discuss the use of discrete anisotropy measures to classify general cerebral pathologies in 3D [135] , but do not perform a statistical analysis.
Another branch of texture analysis is the signal processing approach. In its simplest form an image is analyzed in frequency space, i.e., its discrete Fourier transform is the basis for discrimination based on the occurrence of specific frequency components or power changes. A more advanced method is the use of discrete Gabor or wavelet transforms to extract localized frequency information. An example of the latter is the classification of regions in T 1 weighted images of human knees with respect to tissue type [136] . More recently, geometric methods have been used to classify MR images. The main idea is to consider the image as consisting of a number of smaller texture elements whose distribution indicates changes in structural composition. This was demonstrated on human x-ray mammographic images, classifying them with respect to whether radiological findings were present or not, and this method appears suitable to the analysis of relaxometric data as well [137] . Table 5 summarizes the literature on the classification or detection of AD by texture analysis. Up to now this approach has not been used in mouse models, and only Freeborough et al. [133] consider a longitudinal approach (for the tracking of AD).
DISCUSSION AND CONCLUSION
Summarizing the literature, we can conclude that tracking of relaxometric changes, supplemented by parametric image models and the analysis of image features, is a promising approach to the early detection of the characteristic features of Alzheimer's disease in mouse models. T 2 relaxation times were uniformly found to be the best discriminator, whereas T 1 could not sufficiently discriminate between mutants and their controls. Both changes in T 2 * and T 1rho were found to correlate with aging as well, which warrants further research efforts.
Plaque burden analysis of in vivo MRI is comparable to the relaxometric approach. Fig. (4) shows the age of mice in weeks for which features of AD are detected with in vivo MRI by several plaque detection methods (light grey bars) and by relaxometric methods.(dark grey bars). Since the APP/PS1 mouse model features a more aggressive progression of pathology development, the results are grouped by APP/PS1 mice and the remaining mice (PS1, Tg2576, and further APP variants).
Direct imaging of plaque burden is very valuable in the creation and validation of mathematical models of plague aggregation. Ultimately, it is desirable to incorporate this knowledge into parametric image models, as this should allow for an increase of sensitivity in the detection of AD from relaxometric images. This is further substantiated by the success of texture analysis of MR images. Unfortunately, the few studies undertaken in this regard are phenomenological, and a truly convincing solution for the early detection of Alzheimer s disease does not yet exist. Related to this is the important problem at which size senile plaques are detectable under a prescribed significance level.
As for the volumetric analysis of MRI data, research in human patients has shown that this approach allows the prediction of the development of AD in patients already suffering from Mild Cognitive Impairment (which does not necessarily lead to AD). However, in small animal research this approach is still in an early phase of development. Obviously, it is difficult to detect and quantify cognitive impairment in animals (confer [138, 139] though). The quantification of cerebral amyloid angiopathy by MRA also appears to be promising; especially in tracking the progression of the disease. However, this is again a mostly unexplored area. It has been demonstrated that early detection of AD is feasible by these two approaches, but the results as yet are not as convincing as when employing relaxometric data.
In general, MR imaging is very attractive due to its noninvasiveness and its ability to produce images of high quality, and thus very suitable to study Alzheimer s disease in transgenic mouse models. When performing in vivo imaging on transgenic mice environmental factors, such as the use of anesthetics, stress caused by the imaging process, or even the specific mouse strain used are all confounding factors that influence imaging results [140] . Therefore it is necessary to also study the influence of environmental factors in transgenic mouse models of AD, especially in longitudinal or cognitive studies, where the choice of a correct statistical model is important. If sufficient data is available, these effects can be modeled and estimated, for example in a GLM.
Automated analysis of MR images is a nontrivial task. The relatively large differences between scanners, the possibility of artifacts, and the large number of scanning parame- ters demand standardized imaging protocols and involved methods of image analysis. Automated analysis methods can overcome some of the problems associated with low spatial resolution, low signal-to-noise ratio and inter-group variability, but it seems that there is still a need for the development of new imaging protocols that are specifically targeted at the visualization of amyloid plagues and other symptoms of AD.
With regards to the literature, a striking general observation is that there are relatively few longitudinal studies, and almost no effort to utilize temporal information in the detection of AD. On one hand, it is not immediately obvious how to do this. On the other hand, the main problem in discrimination tasks is the following: There do exist significant differences between groups of diseased individuals and groups of controls, as the above cited studies have shown. On the level of the individual, however, the (usually considerable) overlap between the two populations renders correct classification difficult. But by following an individual through the course of time, even if it is only a few measurements over the course of a few months, changes can be detected that are otherwise unnoticeable. We believe that this is the key to an early detection of AD, and expect that future studies will be conducted in this direction.
To conclude, small animal imaging will always be ahead of imaging in human patients, as small animals can be exposed to higher field strengths and their aging process is more rapid. This makes murine models the perfect testbed for the development of detection and screening procedures. Also, small animals provide a way to test and apply new treatment strategies and experimental medication. We should not forget, however, that the ultimate goal of our research efforts is its application to humans. Fig. (4) . Overview of the minimum age at which Alzheimer pathology was detected in in vivo MRI volumes of APP/PS1 mice (upper panel) and the remaining mouse models (lower panel). Dark grey denotes a relaxometric method, light grey denotes that AD pathology was determined by plaque burden analysis. None of the studies used contrast agents during imaging.
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